Approval · Notice of Compliance 10110 · 2009
SIG-RANITIDINE: Notice of Compliance 10110
Issued March 23, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10110
- Date
- March 23, 2009
- Company
- Sigmacon Lifesciences IncNorth York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Histamine H2-receptor antagonist
- Canadian reference product
- ZANTAC
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIG-RANITIDINE | 02323699 | — |
| SIG-RANITIDINE | 02323702 | — |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB